MAGNI, GIULIO
 Distribuzione geografica
Continente #
NA - Nord America 5.731
EU - Europa 3.928
AS - Asia 1.319
AF - Africa 86
Continente sconosciuto - Info sul continente non disponibili 14
SA - Sud America 9
OC - Oceania 2
Totale 11.089
Nazione #
US - Stati Uniti d'America 5.699
UA - Ucraina 1.036
SE - Svezia 693
DE - Germania 487
IE - Irlanda 484
SG - Singapore 439
TR - Turchia 401
DK - Danimarca 392
IT - Italia 287
CN - Cina 250
FI - Finlandia 220
KR - Corea 209
FR - Francia 177
GB - Regno Unito 91
CI - Costa d'Avorio 70
CA - Canada 30
BE - Belgio 22
MA - Marocco 15
EU - Europa 14
NL - Olanda 11
PL - Polonia 7
BR - Brasile 4
CO - Colombia 4
IN - India 4
RU - Federazione Russa 4
GE - Georgia 3
HK - Hong Kong 3
CH - Svizzera 2
CZ - Repubblica Ceca 2
ES - Italia 2
GT - Guatemala 2
IL - Israele 2
LA - Repubblica Popolare Democratica del Laos 2
RO - Romania 2
VN - Vietnam 2
AE - Emirati Arabi Uniti 1
AU - Australia 1
BG - Bulgaria 1
BO - Bolivia 1
BY - Bielorussia 1
GR - Grecia 1
KG - Kirghizistan 1
LK - Sri Lanka 1
LT - Lituania 1
MD - Moldavia 1
MK - Macedonia 1
NG - Nigeria 1
NO - Norvegia 1
NZ - Nuova Zelanda 1
PT - Portogallo 1
SK - Slovacchia (Repubblica Slovacca) 1
UZ - Uzbekistan 1
Totale 11.089
Città #
Jacksonville 1.040
Chandler 532
Boardman 490
Dublin 484
Fairfield 403
New York 367
Wilmington 344
Ashburn 277
Lawrence 208
Princeton 208
San Mateo 208
Woodbridge 173
Singapore 171
Houston 168
Seattle 165
Ann Arbor 160
Des Moines 140
Cambridge 114
Abidjan 70
San Diego 61
Marche 43
Beijing 42
Centro 23
Ottawa 23
Guangzhou 22
Brussels 21
Shanghai 21
Norwalk 19
Izmir 15
Helsinki 14
Los Angeles 14
Wuhan 13
London 12
Milan 12
Venice 10
Jiaxing 9
Amsterdam 6
Dallas 6
Montréal 6
Rome 6
Washington 6
Berlin 5
Jinhua 5
Kilburn 5
Monza 5
Piemonte 5
Wuxi 5
Auburn Hills 4
New Bedfont 4
Nottingham 4
Pune 4
Shenzhen 4
Teramo 4
Turin 4
Warsaw 4
Ancona 3
Binasco 3
Bogotá 3
Caxias do Sul 3
Chek Chue 3
Chizhou 3
Correggio 3
Greenfield 3
Hounslow 3
Kaiserslautern 3
Naples 3
Prescot 3
Saint Petersburg 3
Simi Valley 3
Tbilisi 3
Weihai 3
Zibo 3
Acton 2
Ansbach 2
Ascoli Piceno 2
Bergamo 2
Buffalo 2
Cankaya 2
Carnate 2
Chiswick 2
Dong Ket 2
Forest City 2
Fuzhou 2
Guatemala City 2
Hefei 2
Heze 2
League City 2
Llanover 2
Lucca 2
Modena 2
Mountain View 2
Napoli 2
Pignola 2
Pontecagnano 2
Quanzhou 2
Redwood City 2
Seoul 2
Stockholm 2
Torino 2
Vientiane 2
Totale 6.295
Nome #
Baker's yeast UMP:pyrophosphate phosphoribosyltransferase. Purification, enzymatic and kinetic properties. 175
Inactivation of uridine nucleosidase in yeast. Purification and properties of an inactivating protein. 137
A rise in NAD precursor nicotinamide mononucleotide (NMN) after injury promotes axon degeneration 125
A spectrophotometric method for the assay of pyrimidine 5'-nucleotidase in human erythrocytes. 108
The genetic basis of hemolytic anemia caused by pyrimidine 5' nucleotidase deficiency. 106
Further properties of cytidine deaminase and uridine phosphorylase from E.coli B. 103
Identification of a novel human nicotinamide mononucleotide adenylyltransferase 102
A comparative study of some properties of cytidine deaminase from Escherichia coli and chicken liver 99
Characterization of human nicotinate phosphoribosyltransferase: kinetic studies, structure prediction and functional analysis by site-directed mutagenesis 99
Homology modeling and deletion mutants of human nicotinamide mononucleotide adenylyltransferase isozyme 2: New insights on structure and function relationship. 98
Purification of human cytidine deaminase. Molecular and enzymatic characterization and inhibition by synthetic pyrimidine analogs 96
Purificazione, microsequenziamento, clonaggio ed espressione della pirimidina 5’-nucleotidasi (PN-I) da eritrocita umano e sua identificazione come p36, una proteina indotta dall’interferone. 94
Assay methods for nicotinamide mononucleotide adenylyltransferase of wide applicability 92
Uridine phosphorylase from Escherichia coli B. Enzymatic and molecular properties. 92
Synthesis and biological evaluation of NAD analogs as human pyridine nucleotide adenylyltransferase inhibitors. 91
Carattirizzazione di una preparazione omogenea di NMN adenililtrasferasi da placenta umana. Procedura di purificazione, analisi cinetica e proprietà molecolari. 90
Enzymology of mammalian NAD metabolism in health and disease. 90
Baker's yeast cytidine deaminase: Substrate and inhibitor specificity, and a hypothesis on metabolic and regulatory significance 89
Activation of succinate dehydrogenase by succinate 83
Cytidine deaminase from Escherichia coli B. Enzymatic and molecular properties. 82
Bifunctional NMN adenylyltransferase/ADP-ribose pyrophosphatase: structure and function in bacterial NAD metabolism. 82
Enzymology of NAD+ homeostasis in man 82
Induction of pyrimidine nucleosides metabolizing enzymes in E.coli B 81
Kinetic evidence for covalent phosphoryl-enzyme intermediate in phosphotransferase activity of human red cell pyrimidine nucleotidases 79
WldS protein requires Nmnat activity and a short N-terminal sequence to protect axons in mice 77
The antitumor drug 1,3-bis-(2-chloroethyl)-1-nitrosourea inactivates human NMN adenylyltransferase 77
Unique expression pattern of human nicotinamide mononucleotide adenylyltransferase isozymes in red blood cells 76
Three-minute high-performance liquid chromatographic assay for NMN adenylyltransferase using a 20-mm-long reversed-phase column 76
Crystal structure of human nicotinic acid phosphoribosyltransferase 75
A novel fold revealed by Mycobacterium tuberculosis NAD kinase, a key allosteric enzyme in NADP biosynthesis 74
Evidence for an inhibitory effect exerted by Yeast NMN Adenylyltransferase on Poly(ADP-ribose)-Polymerase activity. 73
WLDS CAN DELAY WALLERIAN DEGENERATION IN MICE WHEN INTERACTION WITH VALOSIN-CONTAINING PROTEIN IS WEAKENED. 72
The Enzymology of Cytosolic Pyrimidine 5'-Nucleotidases: Functional Analysis and Physiopathological Implications. 72
NMN adenylyltransferase from bull testis: purification and properties 71
Pyrimidine nucleoside catabolizing enzymes in Escherichia coli B. 71
Wallerian degeneration of injured axons and synapses is delayed by a Ube4b/Nmnat chimeric gene. 70
Characterization of nicotinamide mononucleotide adenylyltransferase from thermophilic archaea 69
Presence of a specific uridine 5'-monophosphate pyrophosphorylase in baker's yeast. 69
NAD biosynthesis in human placenta: characterization of homogeneous NMN adenylyltransferase. 69
Simultaneous quantification of nicotinamide mononucleotide and related pyridine compounds in mouse tissues by UHPLC–MS/MS 69
Bakers' yeast uridine nucleosidase is a regulatory copper containing protein. 68
Uridine nucleosidase from yeast 67
Nicotinamide mononucleotide adenylyltransferase from Sulfolobus solfataricus 66
Structure of nicotinamide mononucleotide adenylyltransferase: a key enzyme in NAD biosynthesis 66
Baker's yeast uridine nucleosidase. I. Purification to homogeneity 66
Metabolism of NAD+ in the nuclei of human placenta 66
NAD(+) and axon degeneration revisited: Nmnat1 cannot substitute for Wld(S) to delay Wallerian degeneration. 66
ATP:NMN adenylyltransferase: its relationship to poly ADP-ribosylation 66
Clonaggio ed espressione di geni da Mycobacterium tuberculosis coinvolti nella sintesi del NAD. 66
Biosintesi del NAD in microorganismi termofili. NMN adenililtrasferasi da Sulfolobus solfataricus. 66
Homogeneous pyrimidine nucleotidase from human erythrocyte. Enzymatic and molecular properties 66
Induction studies on enzymes involved in the metabolism of pyrimidine nucleosides in E.coli B. 65
A one-step procedure for the purification of uridine phosphorylase from Escherichia coli 65
Baker's yeast nmn adenylyltransferase 65
Purification of human nicotinamide mononucleotide adenylyltransferase 65
5' Nucleotidase: some properties of guinea pig skeletal muscle and bovine milk serum enzyme 64
Biosintesi del NAD in Mycobacterium tubercolosis: clonaggio ed espressione dei geni nadD e nadR. 64
Nicotinamide-mononucleotide adenylyltransferase from Methanococcus jannaschii 64
Characterization of Mycobacterium tuberculosis NAD kinase: functional analysis of the full-length enzyme by site-directed mutagenesis. 64
Selective inhibition of nicotinamide adenine dinucleotide kinases by dinucleoside disulfide mimics of nicotinamide adenine dinucleotide analogues 63
Synechocystis sp. slr0787 protein is a novel bifunctional enzyme endowed with both nicotinamide mononucleotide adenylyltransferase and "Nudix" hydrolase activities. 63
Cytidine deaminase from human spleen. 63
Identification and characterization of a second NMN adenylyltransferase gene in Saccharomyces cerevisiae 62
Baker's yeast uridine nucleosidase. II. Enzymatic and kinetic properties 62
Bakers' yeast protease a purification and enzymatic and molecular properties 62
Structural and functional properties of NAD kinase, a key enzyme in NADP biosynthesis. 62
Pyridine nucleotide metabolism: Purification and properties of NMN adenylyltransferase from human placenta 62
Nicotinamide mononucleotide synthetase is the key enzyme for an alternative route of NAD biosynthesis in Francisella tularensis. 62
Caratterizzazione strutturale e funzionale dell’NMN adeniltrasferasi umana ricombinante. 61
Baker's yeast cytosine deaminase. Some enzymic properties and allosteric inhibition by nucleosides and nucleotides 60
The Escherichia coli NadR regulator is endowed with nicotinamide mononucleotide adenylyltransferase activity. 60
Molecular cloning, chromosomal localization, tissue mRNA levels, bacterial expression, and enzymatic properties of human NMN adenylyltransferase 59
NAD biosynthesis in human placenta: purification and characterization of homogeneous NMN adenylyltransferase 59
Uridine phosphorylase from Escherichia coli B.: Kinetic studies on the mechanism of catalysis 59
Reducing expression of NAD+ synthesizing enzyme NMNAT1 does not affect the rate of Wallerian degeneration. 59
Characteristics of 5'-nucleotidase in milk 58
Spectrophotometric assays for 5'-nucleotidase, using IMP, GMP and CMP as substrates 58
Initial-rate kinetics of human NMN-adenylyltransferases: substrate and metal ion specificity, inhibition by products and multisubstrate analogues, and isozyme contributions to NAD+ biosynthesis. 58
Biosintesi del NAD: studi preliminari sull'NMN adenililtrasferasi da Sulfolobus solfataricus. 58
Baker's yeast UMP:pyrophosphate phosphoribosyltransferase. Purification, enzymatic and molecular properties. 57
Approccio allo studio della sequenza della NMN adenililtrasferasi da testicolo bovino. 57
Structure and function of nicotinamide mononucleotide adenylyltransferase 57
Identification of the archaeal NMN adenylyltransferase gene. 57
Dinucleoside polyphosphate NAD analogs as potential NMN adenylyltransferase inhibitors. Synthesis and biological evaluation 56
Pyrimidine nucleotidases/phosphotransferases from human erythrocyte. 56
ATP:NMN adenylyltransferase from baker's yeast: further properties 55
Attività fosfotrasferasica di nucleotidasi pirimidiniche nel globulo rosso umano. 55
Azione di diversi effettori sul comportamento cinetico dell'NMN adenililtrasferasi da placenta umana. 55
Bakers' yeast uridine nucleosidase. Purification, composition, and physical and enzymatic properties 54
NAD(P) biosynthesis enzymes as potential targets for selective drug design. 54
Properties of 5′-nucleotidase from Bacillus cereus obtained by washing intact cells with water 53
Expression studies of NMN adenylyltransferase in human cultured cell lines. 53
NMN:ATP adenylyltransferase: its relationship to poly(ADP-ribosylation). 53
Simultaneous single-sample determination of NMNAT isozyme activities in mouse tissues 53
Escherichia coli NadR regulator is endowed with nicotinamide mononucleotide adenylyltransferase activity 53
Biosintesi del NAD: studi sulle proprietà strutturali e funzionali dell'NMN adenililtrasferasi da placenta umana. 52
Caratterizzazione di una preparazione omogenea di NMN adenililtrasferasi da placenta umana. Procedura di purificazione, analisi cinetica e proprietà molecolari. 52
Metabolismo del NAD+ in placenta umana: NMN adenililtrasferasi. 52
Nuclear matrix associated NMN adenylyltransferase activity in human placenta 52
Comparative study of mitochondrial and cytosol proteinphosphatase. 51
Totale 7.127
Categoria #
all - tutte 60.768
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 60.768


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020987 0 0 0 0 212 12 220 7 223 14 28 271
2020/20212.276 62 276 313 16 287 92 331 130 284 124 265 96
2021/20221.248 44 396 5 74 5 55 45 91 121 83 54 275
2022/20232.183 229 248 222 129 147 270 6 133 668 12 68 51
2023/20241.429 252 37 75 240 242 369 17 24 1 11 7 154
2024/2025852 315 244 174 57 62 0 0 0 0 0 0 0
Totale 11.287